
Quick answer: Select pharmaceutical reactors: GMP documentation, cleanability, containment, inert blanketing and sizing for validated chemistry.
Pharmaceutical reactors add GMP documentation, cleanability and containment to standard reactor duties. Batch jacketed reactors remain standard for multi-product plants, with sizing still set by heat balance and viscosity.
Pharmaceutical and fine chemical reactors carry the same unit operations as any chemical reactor - reaction, mixing, heat transfer - but add documentation, cleanability and containment as first-class selection criteria. A buyer comparing "pharmaceutical reactors" is not just asking what type of vessel to use; they are asking how to run validated, traceable, contaminant-controlled chemistry. This guide covers the reactor types used in pharma, what GMP and containment add, and how to select the right unit.
Key takeaways
- Pharma reactors add GMP documentation, cleanability and containment to standard reactor duties
- Batch jacketed reactors remain standard for multi-product pharma and fine chemical plants
- Materials, surface finish and cleaning validation decide changeover safety
- Containment and inert blanketing matter for potent or solvent-based steps
- Sizing still follows heat balance, viscosity and cycle time, not vessel volume alone
Reactor types used in pharma
The same basic types appear in pharma as elsewhere: batch stirred tanks for multi-product campaigns, semi-batch (fed-batch) for exothermic or foaming chemistry, and continuous reactors where a single product runs steadily. What changes is the surrounding requirement set. POLYC supplies jacketed chemical and resin reactors from 100 L up to 20,000 L, with electrical heating reactors at 100-10,000 L and heating power of 6-200 kW depending on vessel and duty, and temperature capability up to about 300 C.
What GMP adds to reactor selection
Good Manufacturing Practice shifts the criteria from "does it react" to "can you prove it reacted the same way every time". That means documented materials of construction, traceable welding and surface finish, validated cleaning procedures, and recipe records tied to each batch. A pharma reactor is selected as much on its documentation and cleanability as on its agitation geometry.
Cleanability and changeover
Between products, the vessel must be cleaned to a validated limit. Smooth internal finishes (typically polished stainless steel 316L), accessible geometries without dead legs, and CIP-capable spray systems make cleaning faster and more reliable. Where products are potent or cross-contamination is unacceptable, dedicated or fully contained lines replace simple changeover.
Containment and safety
Many pharma and fine chemical steps involve potent compounds or flammable solvents. Containment (closed charging, contained sampling, filtered vents) and inert blanketing (nitrogen) become selection criteria alongside capacity. Explosion-proof electricals and solvent recovery are specified together with the reactor when a solvent-based route is involved.
Pharma reactor selection factors
| Factor | Standard plant | Pharma / fine chemical |
|---|---|---|
| Documentation | Basic specs | Material certs, weld maps, IQ/OQ support |
| Surface finish | Industrial 304/316L | Polished 316L, validated cleaning |
| Changeover | Manual clean | CIP, contained or dedicated lines |
| Charging | Open or closed | Closed, contained sampling/venting |
| Atmosphere | Air | Inert blanketing for solvent routes |
Sizing still follows the physics
Even in pharma, the real limit is rarely nominal volume. Heat release rate, viscosity change through the batch, and required cycle time set the vessel and agitator. Anchor and paddle agitators keep heat-transfer surfaces clean in viscous steps; turbine and dispersing discs give high shear for dissolution. Jacketed heating (thermal oil, steam or electric) and vacuum provision for stripping are selected against the duty, not added by default.
Selection checklist
- How many products will this vessel run, and what cleaning limit applies?
- Does the chemistry need containment, inert blanketing or solvent recovery?
- What documentation and finish does GMP require for this step?
- Is the reaction exothermic, and what is the peak heat-release rate?
- Which contact material and surface finish does the product demand?
Reactor and emulsifying kettle configurations
Reactor specification starts from the vessel, not the agitator. The emulsifying kettle range is built in three volumes, each pairing a high-shear emulsifying shaft with a slow anchor mixer:
| Kettle volume (L) | Diameter (mm) | Height (mm) | Emulsifier power (kW) | Emulsifier speed (rpm) | Mixer power (kW) | Mixer speed (rpm) |
|---|---|---|---|---|---|---|
| 1,000 | 1,100 | 1,550 | 11 | 0 - 3,000 | 4 | 60 |
| 2,000 | 1,300 | 1,900 | 18.5 | 0 - 1,450 | 4 | 50 |
| 3,000 | 1,500 | 2,300 | 30 | 0 - 1,450 | 7.5 | 50 |
The emulsifier runs at 0-3,000 rpm on the 1,000 L vessel and 0-1,450 rpm on the 2,000 and 3,000 L vessels, because tip speed is held in a comparable band as the head diameter grows. For resin reactors rather than emulsifying kettles, the catalogue builds 200, 3,000, 5,000, 8,000, 10,000 and 20,000 L vessels, with electric, thermal-oil, steam or zero-distance heating, and external-coil, internal-coil or jacketed construction. Contact parts are SUS 304 or SUS 316 polished; the jacket may be SS 304 or carbon steel. GMP documentation, surface finish and containment requirements should be stated with the enquiry, because they change the construction rather than just the price.
Frequently asked questions
What reactors are used in pharmaceutical production?
Pharma uses the same basic types as other plants: batch stirred tanks for multi-product campaigns, fed-batch reactors for exothermic chemistry, and continuous reactors for steady single products. The difference is the added GMP, cleanability and containment requirements.
What does GMP require from a pharma reactor?
GMP requires documented materials of construction, traceable welding and surface finish, validated cleaning procedures, and recipe records per batch. The reactor is selected as much on documentation and cleanability as on agitation geometry.
Why is cleanability so important in pharma reactors?
Between products the vessel must be cleaned to a validated limit to prevent cross-contamination. Polished 316L finishes, dead-leg-free geometry and CIP-capable sprays make cleaning reliable, and potent products may need contained or dedicated lines.
Do pharmaceutical reactors need special containment?
When the step involves potent compounds or flammable solvents, yes: closed charging, contained sampling, filtered vents and inert (nitrogen) blanketing become selection criteria, with explosion-proof electricals and solvent recovery specified together.
How are pharma reactors sized?
Sizing follows heat-release rate, viscosity change through the batch and required cycle time, not vessel volume alone. Jacketed heating and vacuum stripping are chosen against the duty, with polished 316L contact parts.
Are batch or continuous reactors better for pharma?
Batch jacketed reactors remain standard for multi-product pharma and fine chemical plants because they handle many formulations. Continuous reactors suit a single high-volume product where steady-state consistency is the priority.
Related POLYC equipment
Also covered in this guide: pharmaceutical reactors, types of reactors used in pharma, reactors in pharma industry.
Source: POLYC MACHINE — Shanghai Polyc Technology Co., Ltd. (polyc.site), manufacturer of wet grinding, dispersion and mixing equipment for coatings, inks, adhesives and battery materials since 2006.
Explore POLYC MACHINE bead mills, high-speed dispersers, mixers and reactors for coatings, inks, paints and battery slurry. Request a quote for your process line.
Relevant POLYC MACHINE equipment
Related technical guides
Standards referenced
Method references used by process engineers when specifying and verifying the operations described in this guide.
- ISO 1524:2020 — Paints, varnishes and printing inks — Determination of fineness of grind
- ISO 13320:2020 — Particle size analysis — Laser diffraction methods
- ISO 8780-1:1990 — Pigments and extenders — Methods of dispersion for assessment of dispersion characteristics (Part 1: Introduction)
- ISO 3219 — Plastics — Determination of viscosity using a rotational viscometer
